Clinical trial MBS8-101
A phase I, multicenter, open-label, dose escalation study to determine the safety and preliminary efficacy of MBS8(1V270) administered intravenously to cancer patients with advanced solid tumours (MBS8-101)
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | MonTa Biosciences Aps |
| EudraCT Identifier | 2020-004858-30 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04855435 |
| Last update |